More Globe Newswire

View Older Stories View Newer Stories

May 5, 2025 08:00AM Healthy Choice Wellness Corp. Completes Second Tranche of Debt-for-Equity Conversion
May 5, 2025 08:00AM IDI Integrates with Ping Identity’s PingOne DaVinci to Deliver Powerful Identity Insights Across the Consumer Journey
May 5, 2025 08:00AM GraniteShares ETFs Announces Change to the Investment Objective on one of its Inverse Leveraged ETFs
May 5, 2025 08:00AM Sagitec Awarded MainePERS Project for a Modern Pension Administration System
May 5, 2025 08:00AM ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2025 Financial Results
May 5, 2025 08:00AM Greif, Inc. Announces 2025 Second Quarter Earnings Release and Conference Call Dates
May 5, 2025 08:00AM STMicroelectronics Announces Status of Common Share Repurchase Program
May 5, 2025 08:00AM ASML reports transactions under its current share buyback program
May 5, 2025 07:50AM Articles of Association for Ringkjøbing Landbobank A/S
May 5, 2025 07:45AM Restaurant sales projected to contract in 2025 amid trade war with U.S., despite a strong start to the year thanks to the GST/HST holiday
May 5, 2025 07:45AM Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
May 5, 2025 07:39AM Implementation of capital reduction
May 5, 2025 07:35AM Hazer and KBR Enter Global Deal to Accelerate Licensing and Commercialisation
May 5, 2025 07:35AM Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
May 5, 2025 07:30AM Revival Gold Files NI 43-101 Preliminary Economic Assessment for the Mercur Gold Project
May 5, 2025 07:30AM Stardust Power and OG&E Finalize Key Infrastructure Agreement to Power One of North America’s Largest Proposed Lithium Refineries Located in Muskogee, Oklahoma
May 5, 2025 07:30AM Stardust Power and OG&E Finalize Key Infrastructure Agreement to Power One of North America’s Largest Proposed Lithium Refineries Located in Muskogee, Oklahoma
May 5, 2025 07:30AM Tyson Foods Reports Second Quarter 2025 Results
May 5, 2025 07:30AM Matador Announces Proposed Change of Business to Technology/Investment Issuer
May 5, 2025 07:30AM SEED Therapeutics Highlights Breakthrough Advances in Targeted Protein Degradation at AACR 2025
May 5, 2025 07:30AM Watsco Acquires Southern Ice Equipment Distributors
May 5, 2025 07:30AM Vencora Expands Presence in Australia with Acquisition of Data Action
May 5, 2025 07:30AM American Tungsten Corp. Announces Changes to Board of Directors
May 5, 2025 07:30AM Palvella Therapeutics to Ring the Nasdaq Opening Bell on May 12, 2025
May 5, 2025 07:30AM SEALSQ’s VaultIC 408 Meets FIPS 140-3 Requirements, Advancing NIST Certification and Strengthening Leadership in Secure IoT and Smart Grid Solutions
May 5, 2025 07:30AM SunHydrogen Contracts The Process Group for Front-End Engineering Design of 25m2 Renewable Hydrogen Pilot Plant
May 5, 2025 07:30AM Creative Realities, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Information
May 5, 2025 07:30AM Annual General Meeting of Orrön Energy AB
May 5, 2025 07:08AM Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
May 5, 2025 07:08AM Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
May 5, 2025 07:08AM Goliath Resources Engages JDS Energy & Mining Inc. To Forge Plans To Drive An Exploration Adit At Its Surebet Discovery, Golddigger Property, Golden Triangle, B.C.
May 5, 2025 07:08AM Goliath Resources Engages JDS Energy & Mining Inc. To Forge Plans To Drive An Exploration Adit At Its Surebet Discovery, Golddigger Property, Golden Triangle, B.C.
May 5, 2025 07:01AM USA Rare Earth Announces Closing of $75 Million PIPE Financing
May 5, 2025 07:00AM BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update
May 5, 2025 07:00AM Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Injected Directly into the Brain for Alzheimer’s Disease in Podium Presentation at the ISCT 2025 Scie
May 5, 2025 07:00AM Microbix’s Clot-Buster Drug Project Advances
May 5, 2025 07:00AM Update to Zijin Put Option and Exclusivity Arrangements
May 5, 2025 07:00AM Asante Projects Transformative Growth in Updated Five-Year Outlook: 500,000+ oz Annual Gold Production by 2028, >$2 Billion in Free Cash Flow, Increased Mineral Reserves
May 5, 2025 07:00AM Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights
May 5, 2025 07:00AM Mobilicom’s Cybersecure Drone and Robotics Solutions to Feature at Key U.S. Defense & Autonomy Industry Events
May 5, 2025 07:00AM As Federal Collections Activity Resumes, More Than One in Five Federal Student Loan Borrowers With a Payment Due are Seriously Delinquent
May 5, 2025 07:00AM MTY Food Group Inc. Announces Results from 2025 Annual General Meeting
May 5, 2025 07:00AM Osisko Metals Intersects 323 Metres Averaging 0.43% Cu at Gaspé Project
May 5, 2025 07:00AM Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®
May 5, 2025 07:00AM Apollo Silver Appoints Ross McElroy as President and CEO
May 5, 2025 07:00AM Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September
May 5, 2025 07:00AM PLBY Group to Report First Quarter 2025 Financial Results on May 15, 2025
May 5, 2025 07:00AM Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma
May 5, 2025 07:00AM TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
May 5, 2025 07:00AM Aptose Provides Clinical Update for the Tuspetinib-based Triple Drug Frontline Therapy in Newly Diagnosed AML Patients from the Phase 1/2 TUSCANY Trial
View Newer Stories View Older Stories